HIV-1 disease progression is associated with bile-salt stimulated lipase (BSSL) gene polymorphism

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Stax, Martijn J ^a   Kootstra, Neeltje A ^b   van't Wout, Angélique B ^b   Tanck, Michael W T ^a   Bakker, Margreet ^a   Pollakis, Georgios ^a   Paxton, William A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BUCELIPASE ALFA; CD209 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CEL PROTEIN, HUMAN; TRIACYLGLYCEROL LIPASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ANTIGEN BINDING; ARTICLE; BSSL GENE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; GENE FUNCTION; GENE PRODUCT; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; PATHOGENESIS; SEROCONVERSION; VIRUS LOAD; VIRUS STRAIN; GENETIC POLYMORPHISM; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; KAPLAN MEIER METHOD; MORTALITY; TANDEM REPEAT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ALLELES; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; GENOTYPE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; KAPLAN-MEIER ESTIMATE; LIPASE; POLYMORPHISM, GENETIC; RECEPTORS, CXCR4; TANDEM REPEAT SEQUENCES;

EID: 84857825617     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032534     Document Type: Article

References (38)

1. Paxton WA, Kang S, (1998) Chemokine receptor allelic polymorphisms: relationships to HIV resistance and disease progression. Semin Immunol 10: 187-194.
2. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, et al. (1997) Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277: 959-965.
3. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, et al. (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279: 389-393.
4. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, et al. (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A 96: 4581-4585.
5. Berger EA, Murphy PM, Farber JM, (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 17: 657-700.
6. Gao X, Bashirova A, Iversen AK, Phair J, Goedert JJ, et al. (2005) AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 11: 1290-1292.
7. Haase AT, (2005) Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 5: 783-792.
8. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, et al. (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597.
9. van Liempt E, Imberty A, Bank CM, van Vliet SJ, van Kooyk Y, et al. (2004) Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens. J Biol Chem 279: 33161-33167.
10. van Liempt E, Bank CM, Mehta P, Garcia-Vallejo JJ, Kawar ZS, et al. (2006) Specificity of DC-SIGN for mannose- and fucose-containing glycans. FEBS Lett 580: 6123-6131.
11. van Kooyk Y, Geijtenbeek TB, (2003) DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 3: 697-709.
12. Guo Y, Feinberg H, Conroy E, Mitchell DA, Alvarez R, et al. (2004) Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol 11: 591-598.
13. Gringhuis SI, den Dunnen J, Litjens M, van der Vlist M, Geijtenbeek TB, (2009) Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. Nat Immunol 10: 1081-1088.
14. Arrighi JF, Pion M, Garcia E, Escola JM, van Kooyk Y, et al. (2004) DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J Exp Med 200: 1279-1288.
15. van Montfort T, Nabatov AA, Geijtenbeek TB, Pollakis G, Paxton WA, (2007) Efficient capture of antibody neutralized HIV-1 by cells expressing DC-SIGN and transfer to CD4+ T lymphocytes. J Immunol 178: 3177-3185.
16. Liu H, Hwangbo Y, Holte S, Lee J, Wang C, et al. (2004) Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1. J Infect Dis 190: 1055-1058.
17. Koizumi Y, Kageyama S, Fujiyama Y, Miyashita M, Lwembe R, et al. (2007) RANTES-28G delays and DC-SIGN- 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs. AIDS Res Hum Retroviruses 23: 713-719.
18. Yearley JH, Kanagy S, Anderson DC, Dalecki K, Pauley DR, et al. (2008) Tissue-specific reduction in DC-SIGN expression correlates with progression of pathogenic simian immunodeficiency virus infection. Dev Comp Immunol 32: 1510-1521.
19. Stax MJ, van Montfort T, Sprenger RR, Melchers M, Sanders RW, et al. (2009) Mucin 6 in seminal plasma binds DC-SIGN and potently blocks dendritic cell mediated transfer of HIV-1 to CD4(+) T-lymphocytes. Virology 391: 203-211.
20. Naarding MA, Dirac AM, Ludwig IS, Speijer D, Lindquist S, et al. (2006) Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells. Antimicrob Agents Chemother 50: 3367-3374.
21. Saeland E, de Jong MA, Nabatov AA, Kalay H, Geijtenbeek TB, et al. (2009) MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells. Mol Immunol 46: 2309-2316.
22. Naarding MA, Ludwig IS, Groot F, Berkhout B, Geijtenbeek TB, et al. (2005) Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes. J Clin Invest 115: 3256-3264.
23. Panicot-Dubois L, Thomas GM, Furie BC, Furie B, Lombardo D, et al. (2007) Bile salt-dependent lipase interacts with platelet CXCR4 and modulates thrombus formation in mice and humans. J Clin Invest 117: 3708-3719.
24. McKillop AM, O'Hare MM, Craig JS, Dodge JA, Halliday HL, (1998) Incidence of molecular forms of bile salt-stimulated lipase in preterm and term human milk. Pediatr Res 43: 101-104.
25. O'Brien TR, Busch MP, Donegan E, Ward JW, Wong L, et al. (1994) Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J Acquir Immune Defic Syndr 7: 705-710.
26. Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW, (2002) Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 29: 38-43.
27. Shapiro RL, Smeaton L, Lockman S, Thior I, Rossenkhan R, et al. (2009) Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana. J Infect Dis 199: 414-418.
28. Jin F, Jansson J, Law M, Prestage GP, Zablotska I, et al. (2010) Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART. AIDS 24: 907-913.
29. Aubert-Jousset E, Garmy N, Sbarra V, Fantini J, Sadoulet MO, et al. (2004) The combinatorial extension method reveals a sphingolipid binding domain on pancreatic bile salt-dependent lipase: role in secretion. Structure 12: 1437-1447.
30. Stax MJ, Naarding MA, Tanck MW, Lindquist S, Hernell O, et al. (2011) Binding of human milk to pathogen receptor DC-SIGN varies with bile salt-stimulated lipase (BSSL) gene polymorphism. PLoS one 6: e17316.
31. van Montfort T, Thomas AA, Pollakis G, Paxton WA, (2008) Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in trans. J Virol 82: 7886-7896.
32. Koot M, van LR, de Goede RE, Keet IP, Danner S, et al. (1999) Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis. J Infect Dis 179: 254-258.
33. Moser B, Loetscher P, (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2: 123-128.
34. Wu Y, Yoder A, (2009) Chemokine coreceptor signaling in HIV-1 infection and pathogenesis. PLoS Pathog 5: e1000520.
35. van Manen D, Kootstra NA, Boeser-Nunnink B, Handulle MA, van't Wout AB, et al. (2009) Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 23: 19-28.
36. Koning FA, Otto SA, Hazenberg MD, Dekker L, Prins M, et al. (2005) Low-level CD4+ T cell activation is associated with low susceptibility to HIV-1 infection. J Immunol 175: 6117-6122.
37. Center for Disease Control (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41: 1-19.
38. Koot M, Vos AH, Keet RP, de Goede RE, Dercksen MW, et al. (1992) HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 6: 49-54.